ICPE

Oral presentations

  • Aspirin and gastrointestinal malignancies; improved survival not only in colorectal cancer?
  • Relationship between glycaemic burden and micro- and macrovascular complications in patients with type 2 diabetes mellitus
  • Risk of acute myocardial infarction associated with non-insulin blood glucose lowering drugs. Results from the SAFEGUARD project
  • Use of noninsulin blood glucose lowering drugs and the risk of acute pancreatitis
  • Propranolol use and survival from breast cancer: A pooled analysis of 133,251 breast cancer patients from the European Cancer Pharmacoepidemiology Network
  • Risk of lymphoma in users of topical tacrolimus, pimecrolimus and corticosteroids (JOELLE study)

Poster presentations

Cardiovascular diseases

  • Prescription behaviour for gastroprotective drugs in new users as a result of communications regarding clopidogrel – proton pump inhibitor interaction
  • Clinical characteristics, lipid treatment and goal attainment in a familial hypercholesterolemia cohort in the Netherlands: A cross sectional study

Diabetes

  • Association between type 2 diabetes mellitus and cancer – A methodological approach
  • Renal function measurements in diabetes patients; a population based study in the Netherlands
  • Factors associated with type 2 diabetes mellitus treatment choice across Europe
  • Intensification of basal insulin treatment among patients with type 2 diabetes mellitus in the Netherlands
  • Risk of hemorrhagic stroke associated with non-insulin blood glucose lowering drugs. Results from the SAFEGUARD project

Oncology

  • Association between insulin treatment and breast cancer characteristics
  • A population based study of metformin and the association with survival in pancreatic cancer patients
  • Risk of skin cancer in users of topical tacrolimus, pimecrolimus and corticosteroids. JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) study
  • Utilization of tacrolimus and pimecrolimus in Europe: results from the JOint European Longitudinal Lymphoma and skin cancer Evaluation (JOELLE) study

Women’s health and paediatrics

  • Cyproterone/ethinylestradiol and concomitant use of other hormonal contraceptives in the Netherlands
  • Cyproterone/ethinylestradiol use and indications in the Netherlands
  • Spontaneous Preterm Labour (SPTL) in the Netherlands: creation of linked mother-child cohorts for epidemiological studies

Other

  • Drug utilization study of ophthalmic nepafenac in the Netherlands and Denmark
  • Probabilistic bias analysis for unmeasured confounders in a study of users of topical tacrolimus, pimecrolimus and corticosteroids (JOELLE) study